Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 63 * ! | Sun, 8/3/2014, 4:00 PM - 5:50 PM | CC-260 | |
| Missing Data in Safety Evaluation and Observational Studies — Topic Contributed Papers | |||
| Biopharmaceutical Section | |||
| Organizer(s): Freda Cooner, FDA/CDER | |||
| Chair(s): Freda Cooner, FDA/CDER | |||
| 4:05 PM | Missing Data in Safety Evaluation: Experiences and Case Examples — Aloka Chakravarty, FDA | ||
| 4:25 PM | Minimizing Missing Data in the Design of Observational Clinical Studies — Lilly Yue, FDA/CDRH | ||
| 4:45 PM | Discussant: Peter Mesenbrink, Novartis | ||
| 5:05 PM | Discussant: Chenguang Wang, Johns Hopkins Medicine | ||
| 5:25 PM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.